Hos patienter med viralt gennembrud efter 104 uger var resistens- raten lavere i patienter med HBV DNA < 300 kopier/ ml i uge 24, end i patienter med HBV DNA ≥ 300 kopier/ ml i uge 24.
When considering patients with viral breakthrough by 104 weeks, the rate of resistance was lower in patients with HBV DNA < 300 copies/ ml at week 24 than in patients with HBV DNA ≥ 300 copies/ ml at week 24.